CancerNSight® - A powerful, new tool to facilitate strategic decisions when assessing commercial opportunities in oncology.

• Physician Drivers / Influencers: Which regimen attributes drive and influence first- and second-choice regimen selection?
  

• Patient Types / Segments: What are the physician-identified patient types, and how do they influence regimen selection?
  

• Regimen Benchmarking: How do current regimens perform relative to specific attributes?  What are physician perceptions toward these regimens delivering either superior or inferior levels of performance? 

Who will benefit from CancerNSight®?

Business Development and New Product Planning professionals. CancerNSight® is for those who need to:

• Understand the forward-thinking rationale of KOLs with the real-world perceptions of practicing community oncologists
  
  
• Manage the communication dialogue with other departments involved in the development process (i.e., clinical development, marketing research, new product forecasting, etc.)
  
  
• Uncover differentiating product attributes or patient types that can be competitively exploited
  

CancerNSight® also complements other MattsonJack products and services, including CancerMPact® and Oncology Marketing Strategies™. For more information or a demonstration of CancerNSight®, e-mail info@mattsonjack.com or phone 314. 469.7600.